The pharma giant confirmed that Wang Lei, the executive vice president who oversaw AstraZeneca’s rapid expansion in China, is ...

Researchers have found that, in asymptomatic patients, atherosclerosis and its progression are independently associated with all-cause mortality.

A small player like Viking may also win by attracting a partner or even a company that will offer to acquire the biotech.

Background Pulmonary microvasculature alterations are implicated in emphysema pathogenesis, but the association between ...

AbbVie is reaching for the Sky(rizi) as it spent a staggering $51.5 million on TV drug ads for its immunology blockbuster in October. | AbbVie is reaching for the Sky(rizi) as it spent a staggering ...

WILMETTE, Ill., Oct. 24, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MNPR), a clinical-stage biotechnology company focused on developing innovative treatments for patients with unmet medical needs, today ...

After a quarter century as a serial entrepreneur, Eric Lefkofsky wants his latest unicorn, health tech firm Tempus AI, to be the “enduring legacy” of his career. Here’s how he hopes it will ...

Petrelli has experience in the Canadian biotech industry with a background in supporting people development ... also includes ...

GSK remains on fairly stable financial footing, with a debt/EBITDA ratio of 2.1 at the end of 2023 and Haleon taking on close to GBP 10 billion of GSK's debt in the 2022 divestment. With the improving ...

Absci has a long and expensive path to traverse before it can prove the merits of its approach though. Its cash burn is ...

Q3 2024 Earnings Call Transcript October 30, 2024 8:30 AM ETCompany ParticipantsStephen Amato - Senior Director of ...

Today, DELFI Diagnostics, Inc., developer of accessible blood-based liquid biopsy tests that deliver a new way to enhance early cancer detection, is announcing the appointment of Robert Guigley as its ...